The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken

Vaccine

Volumn 25, Issue 19, 2007, Pages 3792-3799

  Dilaveris, Dimitrios ^a   Chen, Changlin ^a   Kaiser, Pete ^b   Russell, Peter H ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Chicken cytokines; In ovo vaccination; Lung development; Newcastle disease virus; Vaccine safety

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HITCHNER B1 VACCINE; INTERLEUKIN 18; INTERLEUKIN 4; LIVE VACCINE; NEWCASTLE DISEASE VACCINE; PLASMID DNA; POULVAC OVOLINE; RECOMBINANT PROTEIN; ULSTER 2C VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BIRD DISEASE; CHICK EMBRYO; CONTROLLED STUDY; DRUG SAFETY; EMBRYO; FETUS MEMBRANE; IMMUNOGENICITY; IN OVO VACCINATION; LETHALITY; LUNG DEVELOPMENT; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; POULTRY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; STRAIN DIFFERENCE; VACCINATION; VIRUS VIRULENCE; VITELLINE MEMBRANE;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CHICK EMBRYO; CHICKENS; LUNG; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; OVUM; POULTRY DISEASES; TREATMENT OUTCOME; VACCINATION; VIRAL VACCINES;

EID: 34247125627     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.115     Document Type: Article

References (26)

1. Capua I., Pozza M.D., Mulinelli F., Marangon S., and Terregino C. Newcastle disease outbreaks in Italy during 2000. Vet Rec 150 18 (2002) 565-568
2. Chenault E.A. Exotic Newcastle disease confirmed in Texas poultry flock (2003), Agricultural Communications Texas A&M University p. 28-30
3. Sharma J.M., and Burmester B.R. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the Turkey herpesvirus. Avian Dis 26 1 (1982) 134-149
4. Liu C., and Bang F.B. An analysis of the difference between a destructive and a vaccine strain of NDV (Newcastle disease virus) in the chick embryo. J Immunol 70 6 (1953) 538-548
5. Haddad E.E., Martin M., Schaeffer J., Burnes K., and Whitfill C. In ovo vaccination against Newcastle disease: field safety evaluation. Proceedings of the Western Poultry Conference (2003) 34-36
6. Anonymous. Poulvac OVOline ND. Summary of product characteristics; 2000. www.hevra.org.
7. Mebatsion T., Verstegen S., Leonarda T.C., de Vaan L.T.C., Römer-Oberdörfer A., and Schrier C.C. A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J Virol 75 1 (2001) 420-428
8. van Eck J.H.H., van Wiltenburg J., and Jaspers D. An Ulster 2C strain-derived Newcastle disease vaccine: efficacy and excretion in maternally immune chickens. Avian Pathol 20 3 (1991) 481-495
9. Astrin S.M., Buss E.G., and Hayward W.S. Endogenous viral genes are non-essential in the chicken. Nature 282 5736 (1979) 339-341
10. Degen W.G., Daal N., Rothwell L., Kaiser P., and Schijns V.E. Th1/Th2 polarization by viral and helminth infection in birds. Vet Microbiol 105 3-4 (2005) 163-167
11. Degen W.G., van Zuilekom H.I., Scholtes N.C., van Daal N., and Schijns V.E. Potentiation of humoral immune responses to vaccine antigens by recombinant chicken IL-18 (rChIL-18). Vaccine 23 33 (2005) 4212-4218
12. Russell P.H., Griffiths P.C., and Cannon M.J. A microwell immunoperoxidase test for screening hybridomas and for diagnosing Newcastle disease virus and Sendai virus. J Immunol Methods 61 2 (1983) 165-170
13. Russell P.H. Newcastle disease virus: virus replication in the Harderian gland stimulates lachrymal IgA; the yolk sac provides early lachrymal IgG. Vet Immunol Immunopathol 37 2 (1993) 151-163
14. Kaiser P., Poh T.Y., Rothwell L., Avery S., Balu S., Pathania U.S., et al. A genomic analysis of chicken cytokines and chemokines. J Interferon Cytokine Res 25 8 (2005) 467-484
15. Tweedie J.W., and Stowell K.M. Quantification of DNA by agarose gel electrophoresis and analysis of the topoisomers of plasmid and M13 DNA following treatment with a restriction endonuclease or DNA topoisomerase I. Biochem Mol Biol Educ 33 1 (2005) 28-33
16. Harlow E., and Lane D. Antibodies, a laboratory manual (1988), Cold Spring Harbor Press
17. Russell P.H., Dwivedi P.N., and Davison T.F. The effects of cyclosporin A and cyclophosphamide on the populations of B and T cells and virus in the Harderian gland of chickens vaccinated with the Hitchner B1 strain of Newcastle disease virus. Vet Immunol Immunopathol 60 1-2 (1997) 171-185
18. Jochemsen P., and Jeurissen S.H.M. The localization and uptake of in ovo injected soluble and particulate substances in the chicken. Poult Sci 8 12 (2002) 1811-1817
19. Maina J.N. A systematic study of the development of the airway (bronchial) system of the avian lung from days 3 to 26 of embryogenesis: a transmission electron microscopic study on the domestic fowl Gallus gallus variant domesticus. Tissue Cell 35 5 (2003) 375-391
20. Johnston S.D., Orgeig S., Lopatko O.V., and Daniels C.B. Development of the pulmonary surfactant system in two oviparous vertebrates. Am J Physiol Regul Integr Comp Physiol 278 2 (2000) 486-493
21. Nagai Y., Shimokata K., Yoshida T., Hamaguchi M., Iinuma M., Maeno K., et al. The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins. J Gen Virol 45 2 (1979) 263-272
22. Russell P.H., and Koch G. Local antibody forming cell responses to the Hitchner B1 and Ulster strains of Newcastle disease virus. Vet Immunol Immunopathol 37 2 (1993) 165-180
23. Mast J., Nanbru C., Decaesstecker M., Lambrecht B., Couvreur B., Meulemans G., et al. Vaccination of chicken embryos with escape mutants of La Sota Newcastle disease virus induces a protective immune response. Vaccine 24 11 (2006) 1756-1765
24. Poston R.M. In ovo NDV vaccination in combination with interferon-type 1 is safe and efficacious. Proceedings of the 49th Western Poultry Disease Conference, Sacramento, CA (2000) 13-17
25. Chu R.S., Targoni O.S., Kreig A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper (Th1) immunity. J Exp Med 186 10 (1997) 1623-1631
26. Worthington K.J., Sargent B.A., Davelaar F.G., and Jones R.C. Immunity to avian pneumovirus infection in turkeys following in ovo vaccination with an attenuated vaccine. Vaccine 21 13-14 (2003) 1355-1362